Literature DB >> 10854358

Prognosis with Parkinson's disease in europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

K Berger1, M M Breteler, C Helmer, D Inzitari, L Fratiglioni, C Trenkwalder, A Hofman, L J Launer.   

Abstract

Data are lacking on the prognosis (institutionalization and death) of PD cases identified in population-based studies. Data from five population-based European studies were compared and pooled. Each study used comparable two-step screening methods to identify cases and performed one or more follow-up examinations of their respective participants after defined periods of time. PD was classified on the basis of questionnaire and clinical data. The studies include 16,143 participants (252 with PD). The relative risk (RR) (95% CI) of death associated with PD was 2.3 (1.8 to 3.0). The risk for death in men with PD (RR 3.1 [2.1 to 4.4]) was higher than in women with PD (RR 1. 8 [1.2 to 5.1]). The rate of institutionalization varied across studies, increased with age, and was considerably higher in PD cases compared to noncases. Women with PD had a fivefold higher risk to live in a care facility than did men with PD. These data on mortality and rate of institutionalization reflect the high burden of PD in the population.

Entities:  

Mesh:

Year:  2000        PMID: 10854358

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Estimated life expectancy of Parkinson's patients compared with the UK population.

Authors:  Lianna S Ishihara; Anne Cheesbrough; Carol Brayne; Anette Schrag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-30       Impact factor: 10.154

2.  Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.

Authors:  Adrienne M Keener; Kimberly C Paul; Aline Folle; Jeff M Bronstein; Beate Ritz
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

3.  Predictors of survival in patients with Parkinson disease.

Authors:  Allison W Willis; Mario Schootman; Nathan Kung; Bradley A Evanoff; Joel S Perlmutter; Brad A Racette
Journal:  Arch Neurol       Date:  2012-05

4.  Cost of illness and its predictors for Parkinson's disease in Germany.

Authors:  Annika E Spottke; Martin Reuter; Olaf Machat; Bernhard Bornschein; Sonja von Campenhausen; Karin Berger; Rudolf Koehne-Volland; Jürgen Rieke; Alexander Simonow; Dirk Brandstaedter; Uwe Siebert; Wolfgang H Oertel; Gudrun Ulm; Richard Dodel
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.

Authors:  Y-F Huang; Y-G Cherng; S P C Hsu; C-C Yeh; Y-C Chou; C-H Wu; T-L Chen; C-C Liao
Journal:  Osteoporos Int       Date:  2015-02-12       Impact factor: 4.507

6.  Long-term survival of Parkinson's disease: a population-based study.

Authors:  M D'Amelio; P Ragonese; L Morgante; A Reggio; G Callari; G Salemi; G Savettieri
Journal:  J Neurol       Date:  2005-07-18       Impact factor: 6.682

7.  A nationwide study of the incidence, prevalence and mortality of Parkinson's disease in the Norwegian population.

Authors:  Brage Brakedal; Lilah Toker; Kristoffer Haugarvoll; Charalampos Tzoulis
Journal:  NPJ Parkinsons Dis       Date:  2022-03-02

Review 8.  Epidemiology of atypical parkinsonian syndromes.

Authors:  Raymond Y Lo
Journal:  Tzu Chi Med J       Date:  2021-01-19

9.  Prospective comorbidity-matched study of Parkinson's disease and risk of mortality among women.

Authors:  Anke C Winter; Pamela M Rist; Julie E Buring; Tobias Kurth
Journal:  BMJ Open       Date:  2016-09-26       Impact factor: 2.692

10.  Mortality of People with Parkinson's Disease in a Large UK-Based Cohort Study: Time Trends and Relationship to Disease Duration.

Authors:  Olaitan Okunoye; Laura Horsfall; Louise Marston; Kate Walters; Anette Schrag
Journal:  Mov Disord       Date:  2021-08-05       Impact factor: 9.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.